Skip to main content
Erschienen in: International Journal of Mental Health and Addiction 3/2017

21.03.2016

User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes

verfasst von: Marie Claire Van Hout, Evelyn Hearne

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Emergence of synthetic cannabinoids (SCBs) in herbal smoking mixtures is a public health concern. New SCB’s such as 5f-AKB48 and 5F-PB-22 have been detected in French seizures and in sudden death post mortems in the US. The aim was to describe development of dependence on herbal smoking mixtures containing the SCB’s, 5f-AKB48 and 5F-PB-22 and subsequent withdrawal syndromes. Dependent users of herbal smoking mixtures known to contain the SCB’s 5f-AKB48 and 5F-PB-22 with an average Severity of Dependence Score (SDS) of 13 were interviewed using a structured guide (three males/three females). Narratives were analysed using the Empirical Phenomenological Psychological (EPP) five step method. Six themes with 68 categories emerged from the analysis. Themes are illustrated as 1) Networks and Product Availability; 2) Drivers and Motives for Use; 3) Effect and Pathways toward Dependence; 4) Poly Substance Use and Comparisons to Natural Cannabis; 5) Dependence and Withdrawal and 6) Self-detoxification Attempts. Two higher levels of abstraction above these theme-levels emerged from the data, with sole use of herbal smoking mixtures containing 5f-AKB48 and 5F-PB-22 centering on the interplay between intense cravings, compulsive all-consuming seeking, use and re-dose behaviours, and fear of the psychiatric and self-harms caused when in withdrawal. This is the first study describing dependence and withdrawal experiences in users dependent on 5f-AKB48 and 5F-PB-22. Given the potential for adverse psychiatric and physical consequences of dependent use, further development of specific clinical responses and clinical research around toxicity and withdrawal severity are warranted.
Literatur
Zurück zum Zitat Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., & Ferreirós, N. (2009). ‘spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry, 44, 832–837. doi:10.1002/jms. 1558.CrossRefPubMed Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., & Ferreirós, N. (2009). ‘spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry, 44, 832–837. doi:10.​1002/​jms.​ 1558.CrossRefPubMed
Zurück zum Zitat Behonick, G., Shanks, K. G., Firchau, D. J., Mathur, G., Lynch, C. F., Nashelsky, M., Jaskierny, D. J., & Meroueh, C. (2014). Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5FPB22. Journal of Analytical Toxicology, 38, 559–562. doi:10.1093/jat/bku048.CrossRefPubMedPubMedCentral Behonick, G., Shanks, K. G., Firchau, D. J., Mathur, G., Lynch, C. F., Nashelsky, M., Jaskierny, D. J., & Meroueh, C. (2014). Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5FPB22. Journal of Analytical Toxicology, 38, 559–562. doi:10.​1093/​jat/​bku048.CrossRefPubMedPubMedCentral
Zurück zum Zitat Brents, L. K., & Prather, P. L. (2014). The K2/spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metabolism Reviews, 46, 72–85. doi:10.3109/03602532.2013.839700.CrossRefPubMed Brents, L. K., & Prather, P. L. (2014). The K2/spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metabolism Reviews, 46, 72–85. doi:10.​3109/​03602532.​2013.​839700.CrossRefPubMed
Zurück zum Zitat Brents, L. K., Reichard, E. E., Zimmerman, S. M., Moran, J. H., Fantegrossi, W. E., & Prather, P. L. (2011). Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PloS One, 6, e21917. doi:10.1371/journal.pone.0021917.CrossRefPubMedPubMedCentral Brents, L. K., Reichard, E. E., Zimmerman, S. M., Moran, J. H., Fantegrossi, W. E., & Prather, P. L. (2011). Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PloS One, 6, e21917. doi:10.​1371/​journal.​pone.​0021917.CrossRefPubMedPubMedCentral
Zurück zum Zitat Brents, L. K., Gallus-Zawada, A., Radominska-Pandya, A., Vasilievik, T., Prisinzano, T. E., Fantegrossi, W. E., Moran, J. H., & Prather, P. L. (2012). Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochemical Pharmacology, 83, 952–961. doi:10.1016/j.bcp.2012.01.004.CrossRefPubMedPubMedCentral Brents, L. K., Gallus-Zawada, A., Radominska-Pandya, A., Vasilievik, T., Prisinzano, T. E., Fantegrossi, W. E., Moran, J. H., & Prather, P. L. (2012). Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochemical Pharmacology, 83, 952–961. doi:10.​1016/​j.​bcp.​2012.​01.​004.CrossRefPubMedPubMedCentral
Zurück zum Zitat Bright, S. J., Bishop, B., Kane, R., Marsh, A., & Barratt, M. J. (2013). Kronic hysteria: exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm. The International Journal on Drug Policy, 24, 231–237. doi:10.1016/j.drugpo.2012.12.002.CrossRefPubMed Bright, S. J., Bishop, B., Kane, R., Marsh, A., & Barratt, M. J. (2013). Kronic hysteria: exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm. The International Journal on Drug Policy, 24, 231–237. doi:10.​1016/​j.​drugpo.​2012.​12.​002.CrossRefPubMed
Zurück zum Zitat Budney, A. J., & Stanger, C. (2012). Cannabis use and misuse. In J. M. Rey (Ed.), IACAPAP e-textbook of child and adolescent mental health (p. G2). Geneva: International Association for Child and Adolescent Psychiatry and Allied Profession. Budney, A. J., & Stanger, C. (2012). Cannabis use and misuse. In J. M. Rey (Ed.), IACAPAP e-textbook of child and adolescent mental health (p. G2). Geneva: International Association for Child and Adolescent Psychiatry and Allied Profession.
Zurück zum Zitat Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., Sanci, L., & Patton, G. C. (2002). Cannabis dependence in young adults: an Australian population study. Addiction, 97, 187–194.CrossRefPubMed Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., Sanci, L., & Patton, G. C. (2002). Cannabis dependence in young adults: an Australian population study. Addiction, 97, 187–194.CrossRefPubMed
Zurück zum Zitat Copersino, M. L., Boyd, S. J., Tashkin, D. P., Huestis, M. A., Heishman, S. J., Dermand, J. C., Simmons, M. S., & Gorelick, D. A. (2006). Cannabis withdrawal among non-treatment-seeking adult cannabis users. The American Journal on Addictions, 15, 8–14.CrossRefPubMed Copersino, M. L., Boyd, S. J., Tashkin, D. P., Huestis, M. A., Heishman, S. J., Dermand, J. C., Simmons, M. S., & Gorelick, D. A. (2006). Cannabis withdrawal among non-treatment-seeking adult cannabis users. The American Journal on Addictions, 15, 8–14.CrossRefPubMed
Zurück zum Zitat Deluca, P., Schifano, F., Davey, Z., Corazza, O., di Furia, L., Farre, M., Flesland, L., Mannonen, M., Majava, A., Valentina, M., Pagani, S., Peltoniemi, T., Scherbaum, N., Siemann, H., Skutle, A., Torrens, M., Pezzolesi, C., & van der Kreeft, P. (2009). Spice report Psychonaut Web Mapping Research Project. King’s College London: The Psychonaut Web Mapping Research Group. Deluca, P., Schifano, F., Davey, Z., Corazza, O., di Furia, L., Farre, M., Flesland, L., Mannonen, M., Majava, A., Valentina, M., Pagani, S., Peltoniemi, T., Scherbaum, N., Siemann, H., Skutle, A., Torrens, M., Pezzolesi, C., & van der Kreeft, P. (2009). Spice report Psychonaut Web Mapping Research Project. King’s College London: The Psychonaut Web Mapping Research Group.
Zurück zum Zitat Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., & Auwarter, V. (2011). Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46, 163–171. doi:10.1002/jms.1877.CrossRefPubMed Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., & Auwarter, V. (2011). Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46, 163–171. doi:10.​1002/​jms.​1877.CrossRefPubMed
Zurück zum Zitat Egan, K. L., Suerken, C. K., Reboussin, B. A., Spangler, J., Wagoner, K. G., Sutfin, E. L., Debinski, B., & Wolfson, M. (2015). K2 and spice use among a cohort of college students in southeast region of the USA. The Am J Drug Alcohol Abuse, 41, 317–322. doi:10.3109/00952990.2015.1043438.CrossRefPubMed Egan, K. L., Suerken, C. K., Reboussin, B. A., Spangler, J., Wagoner, K. G., Sutfin, E. L., Debinski, B., & Wolfson, M. (2015). K2 and spice use among a cohort of college students in southeast region of the USA. The Am J Drug Alcohol Abuse, 41, 317–322. doi:10.​3109/​00952990.​2015.​1043438.CrossRefPubMed
Zurück zum Zitat Fantegrossi, W. E., Moran, J. H., Radominska-Pandya, A., & Prather, P. L. (2014). Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: mechanism underlying greater toxicity? Life Sciences, 97, 45–54. doi:10.1016/j.lfs.2013.09.017.CrossRefPubMed Fantegrossi, W. E., Moran, J. H., Radominska-Pandya, A., & Prather, P. L. (2014). Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: mechanism underlying greater toxicity? Life Sciences, 97, 45–54. doi:10.​1016/​j.​lfs.​2013.​09.​017.CrossRefPubMed
Zurück zum Zitat Gillespie, N. A., Neale, M. C., Prescott, C. A., Aggen, S. H., & Kendler, K. S. (2007). Addiction, 10, 920–930.CrossRef Gillespie, N. A., Neale, M. C., Prescott, C. A., Aggen, S. H., & Kendler, K. S. (2007). Addiction, 10, 920–930.CrossRef
Zurück zum Zitat Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607–614.CrossRefPubMed Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607–614.CrossRefPubMed
Zurück zum Zitat Grigoryev, A., Melnik, A., Savchuk, S., Simonov, A., & Rozhanets, V. (2011a). Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879, 2519–2526. doi:10.1016/j.jchromb.2011.07.004.CrossRefPubMed Grigoryev, A., Melnik, A., Savchuk, S., Simonov, A., & Rozhanets, V. (2011a). Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879, 2519–2526. doi:10.​1016/​j.​jchromb.​2011.​07.​004.CrossRefPubMed
Zurück zum Zitat Grigoryev, A., Savchuk, S., Melnik, A., Moskaleva, N., Dzhurko, J., Ershov, M., Nosyrev, A., Vedenin, A., Izotov, B., Zabirova, I., & Rozhanets, V. (2011b). Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879, 1126–1136. doi:10.1016/j.jchromb.2011.03.034.CrossRefPubMed Grigoryev, A., Savchuk, S., Melnik, A., Moskaleva, N., Dzhurko, J., Ershov, M., Nosyrev, A., Vedenin, A., Izotov, B., Zabirova, I., & Rozhanets, V. (2011b). Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 879, 1126–1136. doi:10.​1016/​j.​jchromb.​2011.​03.​034.CrossRefPubMed
Zurück zum Zitat Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2012). “spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. The American Journal on Addictions, 21, 320–326. doi:10.1111/j.1521-0391.2012.00240.x.CrossRefPubMed Gunderson, E. W., Haughey, H. M., Ait-Daoud, N., Joshi, A. S., & Hart, C. L. (2012). “spice” and “K2” herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. The American Journal on Addictions, 21, 320–326. doi:10.​1111/​j.​1521-0391.​2012.​00240.​x.CrossRefPubMed
Zurück zum Zitat Helander, A., Beck, O., Hägerkvist, R., & Hulthén, P. (2013). Identification of novel psychoactive drug use in Sweden based on laboratory analysis: initial experiences from the STRIDA project. Scandinavian Journal of Clinical and Laboratory Investigation, 73, 400–406. doi:10.3109/00365513.2013.793817.CrossRefPubMed Helander, A., Beck, O., Hägerkvist, R., & Hulthén, P. (2013). Identification of novel psychoactive drug use in Sweden based on laboratory analysis: initial experiences from the STRIDA project. Scandinavian Journal of Clinical and Laboratory Investigation, 73, 400–406. doi:10.​3109/​00365513.​2013.​793817.CrossRefPubMed
Zurück zum Zitat Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P. I., & Wood, D. M. (2010). Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in “herbal high” products. Journal of Analytical Toxicology, 34, 252–260.CrossRefPubMed Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P. I., & Wood, D. M. (2010). Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in “herbal high” products. Journal of Analytical Toxicology, 34, 252–260.CrossRefPubMed
Zurück zum Zitat Husserl, E. (1970). Logical investigation. New York: Humanities Press. Husserl, E. (1970). Logical investigation. New York: Humanities Press.
Zurück zum Zitat Johnston, L. D., O’Malley, P. M., Miech, R. A., Bachman, J. G., & JE, S. (2015). Monitoring the Future national survey results on drug use: 1975-2014: Overview, key findings on adolescent drug use. Institute For Social Research. Ann Arbor, MI: The University of Michigan. Johnston, L. D., O’Malley, P. M., Miech, R. A., Bachman, J. G., & JE, S. (2015). Monitoring the Future national survey results on drug use: 1975-2014: Overview, key findings on adolescent drug use. Institute For Social Research. Ann Arbor, MI: The University of Michigan.
Zurück zum Zitat Karlsson, G. (1995). Psychological qualitative research from a phenomenological perspective. Stockholm, Sweden: Almqvist & Wiksell International. Karlsson, G. (1995). Psychological qualitative research from a phenomenological perspective. Stockholm, Sweden: Almqvist & Wiksell International.
Zurück zum Zitat Kjellgren, A., & Jonsson, K. (2013). Methoxetamine (MXE)–a phenomenological study of experiences induced by a “legal high” from the internet. Journal of Psychoactive Drugs, 45, 276–286.CrossRefPubMedPubMedCentral Kjellgren, A., & Jonsson, K. (2013). Methoxetamine (MXE)–a phenomenological study of experiences induced by a “legal high” from the internet. Journal of Psychoactive Drugs, 45, 276–286.CrossRefPubMedPubMedCentral
Zurück zum Zitat Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage. Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage.
Zurück zum Zitat McElrath, K., & Van Hout, M. C. (2011). A preference for mephedrone: Drug Markets, drugs of choice and the emerging ‘legal high’ scene. Journal of Drug Issues, 41, 487–507.CrossRef McElrath, K., & Van Hout, M. C. (2011). A preference for mephedrone: Drug Markets, drugs of choice and the emerging ‘legal high’ scene. Journal of Drug Issues, 41, 487–507.CrossRef
Zurück zum Zitat Meshack A, Peters RJ.Jr, Mi-Ting L, Hill M, Abughosh S, Essien EJ, Savage C (2013) The beliefs of teenage male cannabinoid users: a qualitative study. American Journal of Health Studies 28:109–113. Meshack A, Peters RJ.Jr, Mi-Ting L, Hill M, Abughosh S, Essien EJ, Savage C (2013) The beliefs of teenage male cannabinoid users: a qualitative study. American Journal of Health Studies 28:109–113.
Zurück zum Zitat Müller, H., Huttner, H. B., Kohrmann, M., Wielopolski, J. E., Kornhuber, J., & Sperling, W. (2010a). Panic attack after spice abuse in a patient with ADHD. Pharmacopsychiatry, 43, 152–153. doi:10.1055/s-0029-1243252.CrossRefPubMed Müller, H., Huttner, H. B., Kohrmann, M., Wielopolski, J. E., Kornhuber, J., & Sperling, W. (2010a). Panic attack after spice abuse in a patient with ADHD. Pharmacopsychiatry, 43, 152–153. doi:10.​1055/​s-0029-1243252.CrossRefPubMed
Zurück zum Zitat Müller, H., Sperling, W., Kohrmann, M., Huttner, H. B., Kornhuber, J., & Maler, J. M. (2010b). The synthetic cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophrenia Research, 118, 309–310. doi:10.1016/j.schres.2009.12.001.CrossRefPubMed Müller, H., Sperling, W., Kohrmann, M., Huttner, H. B., Kornhuber, J., & Maler, J. M. (2010b). The synthetic cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophrenia Research, 118, 309–310. doi:10.​1016/​j.​schres.​2009.​12.​001.CrossRefPubMed
Zurück zum Zitat Pierre, J. M. (2011). Cannabis, synthetic cannabinoids, and psychosis risk: what the evidence says: research suggests marijuana may be a ‘component cause’ of psychosis. Current Psychology, 10, 9. Pierre, J. M. (2011). Cannabis, synthetic cannabinoids, and psychosis risk: what the evidence says: research suggests marijuana may be a ‘component cause’ of psychosis. Current Psychology, 10, 9.
Zurück zum Zitat Rominger, A., Cumming, P., Xiong, G., Koller, G., Forster, S., Zwergal, A., Karamatskos, E., Bartenstein, P., La Fougere, C., & Pogarell, O. (2013). Effects of acute detoxification of the herbal blend ‘spice gold’ on dopamine D2/3 receptor availability: a [18F]fallypride PET study. European Neuropsychopharmacology, 23, 1606–1610. doi:10.1016/j.euroneuro.2013.01.009.CrossRefPubMed Rominger, A., Cumming, P., Xiong, G., Koller, G., Forster, S., Zwergal, A., Karamatskos, E., Bartenstein, P., La Fougere, C., & Pogarell, O. (2013). Effects of acute detoxification of the herbal blend ‘spice gold’ on dopamine D2/3 receptor availability: a [18F]fallypride PET study. European Neuropsychopharmacology, 23, 1606–1610. doi:10.​1016/​j.​euroneuro.​2013.​01.​009.CrossRefPubMed
Zurück zum Zitat Schifano, F., Deluca, P., Baldacchino, A., Peltoniemi, T., Scherbaum, N., Torrens, M., Farre, M., Flores, I., Rossi, M., Eastwood, D., Guionnet, C., Rawaf, S., Agosti, L., Di Furia, L., Brigada, R., Majava, A., Siemann, H., Leoni, M., Tomasin, A., Rovetto, F., & Ghodse, A. H. (2006). Drugs on the web; the Psychonaut 2002 EU project. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30, 640–646.CrossRef Schifano, F., Deluca, P., Baldacchino, A., Peltoniemi, T., Scherbaum, N., Torrens, M., Farre, M., Flores, I., Rossi, M., Eastwood, D., Guionnet, C., Rawaf, S., Agosti, L., Di Furia, L., Brigada, R., Majava, A., Siemann, H., Leoni, M., Tomasin, A., Rovetto, F., & Ghodse, A. H. (2006). Drugs on the web; the Psychonaut 2002 EU project. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30, 640–646.CrossRef
Zurück zum Zitat Schifano, F., Corazza, O., Deluca, P., Davey, Z., Lucia, D. F., Farre, M., Flesland, L., Mannonen, M., Pagani, S., Peltoniemi, T., Pezzolesi, C., Scherbaum, N., Siemann, H., Skutle, A., Torrens, M., & Van Der Kreeft, P. (2009). Psychoactive drug mystical incense? overview of the online available information on spice products. Int J Cult Ment Health, 2, 137–144. doi:10.1080/17542860903350888.CrossRef Schifano, F., Corazza, O., Deluca, P., Davey, Z., Lucia, D. F., Farre, M., Flesland, L., Mannonen, M., Pagani, S., Peltoniemi, T., Pezzolesi, C., Scherbaum, N., Siemann, H., Skutle, A., Torrens, M., & Van Der Kreeft, P. (2009). Psychoactive drug mystical incense? overview of the online available information on spice products. Int J Cult Ment Health, 2, 137–144. doi:10.​1080/​1754286090335088​8.CrossRef
Zurück zum Zitat Schifano, F., Ricciardi, A., Corazza, O., Deluca, P., Davey, Z., & Rafanelli, C. (2010). New drugs of abuse on the Web: the role of the Psychonaut Web Mapping Project. Rivista di Psichiatria, 45, 88–93.PubMed Schifano, F., Ricciardi, A., Corazza, O., Deluca, P., Davey, Z., & Rafanelli, C. (2010). New drugs of abuse on the Web: the role of the Psychonaut Web Mapping Project. Rivista di Psichiatria, 45, 88–93.PubMed
Zurück zum Zitat Seely, K. A., Lapoint, J., Moran, J. H., & Frattore, L. (2012). Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 39, 234–243. doi:10.1016/j.pnpbp.2012.04.017.CrossRef Seely, K. A., Lapoint, J., Moran, J. H., & Frattore, L. (2012). Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 39, 234–243. doi:10.​1016/​j.​pnpbp.​2012.​04.​017.CrossRef
Zurück zum Zitat Soussan, C., & Kjellgren, A. (2014). The flip side of “spice”: the adverse effects of synthetic cannabinoids as discussed on a Swedish internet forum. Nordic Studies on Alcohol and Drugs, 31, 207–220.CrossRef Soussan, C., & Kjellgren, A. (2014). The flip side of “spice”: the adverse effects of synthetic cannabinoids as discussed on a Swedish internet forum. Nordic Studies on Alcohol and Drugs, 31, 207–220.CrossRef
Zurück zum Zitat Tung, C. K., Chiang, T. P., & Lam, M. (2012). Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong. East Asian Arch Psychiatry, 22, 31–33.PubMed Tung, C. K., Chiang, T. P., & Lam, M. (2012). Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong. East Asian Arch Psychiatry, 22, 31–33.PubMed
Zurück zum Zitat Tuv, S. S., Strand, M. C., Karinen, R., Øiestad, E. L., Christophersen, A. S., & Vindenes, V. (2012). Effect and occurrence of synthetic cannabinoids. Tidsskrift for den Norske Lægeforening, 132, 2285–2288. doi:10.4045/tidsskr.12.0471.CrossRefPubMed Tuv, S. S., Strand, M. C., Karinen, R., Øiestad, E. L., Christophersen, A. S., & Vindenes, V. (2012). Effect and occurrence of synthetic cannabinoids. Tidsskrift for den Norske Lægeforening, 132, 2285–2288. doi:10.​4045/​tidsskr.​12.​0471.CrossRefPubMed
Zurück zum Zitat Van Hout, M. C., & Brennan, R. (2011b). Bump and grind: An exploratory study of mephedrone users’ perceptions of sexuality and sexual risk. Drug Alcohol Today, 11, 93–104.CrossRef Van Hout, M. C., & Brennan, R. (2011b). Bump and grind: An exploratory study of mephedrone users’ perceptions of sexuality and sexual risk. Drug Alcohol Today, 11, 93–104.CrossRef
Zurück zum Zitat Van Hout, M. C., & Brennan, R. (2012). Curiosity killed M-cat: A post legislative study on mephedrone use in Ireland. Drugs: Educ Prev Polic, 19, 156–162. Van Hout, M. C., & Brennan, R. (2012). Curiosity killed M-cat: A post legislative study on mephedrone use in Ireland. Drugs: Educ Prev Polic, 19, 156–162.
Zurück zum Zitat Wallendorf, M., & Belk, R. W. (1989). Assessing trustworthiness in naturalistic consumer research. In E. C. Hirschman (Ed.), Interpretive consumer research (pp. 69–84). Provo, UT: Association for Consumer Research. Wallendorf, M., & Belk, R. W. (1989). Assessing trustworthiness in naturalistic consumer research. In E. C. Hirschman (Ed.), Interpretive consumer research (pp. 69–84). Provo, UT: Association for Consumer Research.
Zurück zum Zitat Westphal, F., Junge, T., Sonnichsen, F., Rosner, P., & Schaper, J. (2010). Ein neuer wirkstoff in SPICE-artigen Kräutermischungen: charakterisierung von JWH-250, seinen methyl-und trimethylsilylderivaten [A new compound in herbal mixtures: characterisation of JWH-250, its methyl- and trimethylsilyl-derivatives]. Toxichem Krimtech, 77, 46–58. Westphal, F., Junge, T., Sonnichsen, F., Rosner, P., & Schaper, J. (2010). Ein neuer wirkstoff in SPICE-artigen Kräutermischungen: charakterisierung von JWH-250, seinen methyl-und trimethylsilylderivaten [A new compound in herbal mixtures: characterisation of JWH-250, its methyl- and trimethylsilyl-derivatives]. Toxichem Krimtech, 77, 46–58.
Zurück zum Zitat Zimmermann, U. S., Winkelmann, P. R., Pilhatsch, M., Nees, J. A., Spanagel, R., & Schulz, K. (2009). Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Deutsches Ärzteblatt International, 106, 464–467. doi:10.3238/arztebl.2009.0464.PubMedPubMedCentral Zimmermann, U. S., Winkelmann, P. R., Pilhatsch, M., Nees, J. A., Spanagel, R., & Schulz, K. (2009). Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Deutsches Ärzteblatt International, 106, 464–467. doi:10.​3238/​arztebl.​2009.​0464.PubMedPubMedCentral
Metadaten
Titel
User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes
verfasst von
Marie Claire Van Hout
Evelyn Hearne
Publikationsdatum
21.03.2016
Verlag
Springer US
Erschienen in
International Journal of Mental Health and Addiction / Ausgabe 3/2017
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI
https://doi.org/10.1007/s11469-016-9650-x

Weitere Artikel der Ausgabe 3/2017

International Journal of Mental Health and Addiction 3/2017 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.